Zongxi Li

Molecular Biology · 2010–2012

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Zongxi Li trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Liong

Papers from Zongxi Li's perspective

Ordered by how strongly the researchers Zongxi Li trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
  2. Mechanisms of cancer drug resistance. (Annual Review of Medicine)
  3. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. (Small)
  4. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium
  5. Recent advances in iron oxide nanocrystal technology for medical imaging. (Advanced Drug Delivery Reviews)
  6. Targeted drug delivery via the folate receptor. (Advanced Drug Delivery Reviews)
  7. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Ultra-large-scale syntheses of monodisperse nanocrystals (Nature Materials)
  9. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. (Proceedings of the National Academy of Sciences of the United States of America)
  10. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. (Journal of the American Chemical Society)

Their papers